Psoriatic arthritis trials in Austria

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

  Where

  Bregenz

  Age

  1 year to 18 years

  People

  190 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT03773965
• Phase 3Taking people
  Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis

  Where

  Bregenz

  Age

  5 years to 17 years

  People

  60 worldwide

  Run by

  Amgen

  See details and how to joinNCT04804553 · EU 2023-503435-17-00
• No phaseTaking people
  An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis

  Where

  Graz, Stockerau, Vienna

  Age

  18 years to 75 years

  People

  1,200 worldwide

  Run by

  AbbVie

  See details and how to joinNCT06764693